These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 28411071)

  • 41. Clinicopathological features of recurrence after radical surgery for nonmetastatic renal cell carcinoma.
    Ishimura T; Sakai I; Harada K; Hara I; Eto H; Miyake H
    Int J Clin Oncol; 2004 Oct; 9(5):369-72. PubMed ID: 15549586
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Assessing the accuracy and generalizability of the preoperative and postoperative Karakiewicz nomograms for renal cell carcinoma: results from a multicentre European and US study.
    Cindolo L; Chiodini P; Brookman-May S; De Cobelli O; May M; Squillacciotti S; De Nunzio C; Tubaro A; Coman I; Feciche B; Truss M; Wirth MP; Dalpiaz O; Chromecki TF; Shariat SF; Sanchez-Chapado M; Santiago Martin Mdel C; Rocco B; Salzano L; Lotrecchiano G; Berardinelli F; Schips L
    BJU Int; 2013 Sep; 112(5):578-84. PubMed ID: 23470199
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical and oncological outcomes in Chinese patients with renal cell carcinoma and venous tumor thrombus extension: single-center experience.
    Chen X; Li S; Xu Z; Wang K; Fu D; Liu Q; Wang X; Wu B
    World J Surg Oncol; 2015 Feb; 13():14. PubMed ID: 25650039
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A postoperative prognostic nomogram for renal cell carcinoma.
    Kattan MW; Reuter V; Motzer RJ; Katz J; Russo P
    J Urol; 2001 Jul; 166(1):63-7. PubMed ID: 11435824
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Prognostic Impact of a Positive Vascular Margin on pT3 Clear Cell Renal Cell Carcinoma.
    Liu NW; Wren JD; Vertosick E; Lee JK; Power NE; Benfante NE; Kimm SY; Bains MS; Sjoberg DD; Russo P; Coleman JA
    J Urol; 2016 Feb; 195(2):264-9. PubMed ID: 26363467
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Presence of Vascular Mimicry Predicts High Risk of Clear Cell Renal Cell Carcinoma after Radical Nephrectomy.
    Zhou L; Chang Y; Xu L; Liu Z; Fu Q; Yang Y; Lin Z; Xu J
    J Urol; 2016 Aug; 196(2):335-42. PubMed ID: 26970566
    [TBL] [Abstract][Full Text] [Related]  

  • 47. External validation of the Mayo Clinic stage, size, grade, and necrosis (SSIGN) score for clear-cell renal cell carcinoma in a single European centre applying routine pathology.
    Zigeuner R; Hutterer G; Chromecki T; Imamovic A; Kampel-Kettner K; Rehak P; Langner C; Pummer K
    Eur Urol; 2010 Jan; 57(1):102-9. PubMed ID: 19062157
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prevalence and prognostic value of FBXO11 expression in patients with clear cell renal cell carcinoma.
    Fan B; Wang W; Zhang X; Sun M; Wang X; Chen Z; Liu W; Wang Q; Yu N; Li X
    BMC Cancer; 2019 Jun; 19(1):534. PubMed ID: 31159774
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Renal cell carcinoma with renal vein and inferior vena caval involvement: clinicopathological features, surgical techniques and outcomes.
    Parekh DJ; Cookson MS; Chapman W; Harrell F; Wells N; Chang SS; Smith JA
    J Urol; 2005 Jun; 173(6):1897-902. PubMed ID: 15879771
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Leibovich score is the optimal clinico-pathological system associated with recurrence of non-metastatic clear cell renal cell carcinoma.
    Blackmur JP; Gaba F; Fernando D; Williams S; O'Donnell M; McNeill A; Stewart GD; Leung S; Laird A
    Urol Oncol; 2021 Jul; 39(7):438.e11-438.e21. PubMed ID: 34023196
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Predictors of oncological outcome after resection of locally recurrent renal cell carcinoma.
    Margulis V; McDonald M; Tamboli P; Swanson DA; Wood CG
    J Urol; 2009 May; 181(5):2044-51. PubMed ID: 19286220
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Charlson co-morbidity index as a predictor of outcome after surgery for renal cell carcinoma with renal vein, vena cava or right atrium extension.
    Gettman MT; Boelter CW; Cheville JC; Zincke H; Bryant SC; Blute ML
    J Urol; 2003 Apr; 169(4):1282-6. PubMed ID: 12629343
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A preoperative prognostic model predicting recurrence-free survival for patients with kidney cancer.
    Yaycioglu O; Eskicorapci S; Karabulut E; Soyupak B; Gogus C; Divrik T; Turkeri L; Yazici S; Ozen H;
    Jpn J Clin Oncol; 2013 Jan; 43(1):63-8. PubMed ID: 23159766
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Surgical treatment of renal cell carcinoma: Can morphological features of inferior vena cava tumor thrombus on computed tomography or magnetic resonance imaging be a prognostic factor?
    Choi DK; Jeon HG; Jeong CW; Kwak C; Song C; Chung J; Hong SK; Hong SH; Seo SI;
    Int J Urol; 2017 Feb; 24(2):102-109. PubMed ID: 28111837
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN Project).
    Brookman-May S; May M; Shariat SF; Xylinas E; Stief C; Zigeuner R; Chromecki T; Burger M; Wieland WF; Cindolo L; Schips L; De Cobelli O; Rocco B; De Nunzio C; Feciche B; Truss M; Gilfrich C; Pahernik S; Hohenfellner M; Zastrow S; Wirth MP; Novara G; Carini M; Minervini A; Simeone C; Antonelli A; Mirone V; Longo N; Simonato A; Carmignani G; Ficarra V;
    Eur Urol; 2013 Sep; 64(3):472-7. PubMed ID: 22748912
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Venous tumor thrombus consistency is not predictive of survival in patients with renal cell carcinoma: A retrospective study of 147 patients.
    Antonelli A; Sodano M; Sandri M; Tardanico R; Yarigina M; Furlan M; Galvagni G; Zanotelli T; Cozzoli A; Simeone C
    Int J Urol; 2015 Jun; 22(6):534-9. PubMed ID: 25808349
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Renal cell carcinoma with tumor thrombus extension: biology, role of nephrectomy and response to immunotherapy.
    Zisman A; Wieder JA; Pantuck AJ; Chao DH; Dorey F; Said JW; Gitlitz BJ; deKernion JB; Figlin RA; Belldegrun AS
    J Urol; 2003 Mar; 169(3):909-16. PubMed ID: 12576811
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Development and External Validation of Nomograms for Predicting Disease-Free Survival and Overall Survival in Patients with cT1-ccRCC After Partial Nephrectomy: A Multicenter Retrospective Study.
    Xu H; Xing Z; Wang J; Lv Z; Deng P; Hong Y; Li Y
    Ann Surg Oncol; 2024 Sep; 31(9):5827-5838. PubMed ID: 38971957
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Surgical Management and Outcome of Renal Cell Carcinoma with Inferior Vena Cava Tumor Thrombus.
    Berczi A; Flasko T; Szerafin T; Thomas B; Bacso Z; Berczi C
    Urol Int; 2017; 99(3):267-271. PubMed ID: 28253496
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical impact of segmental renal vein invasion on recurrence in patients with clinical T1 renal cell carcinoma undergoing partial nephrectomy.
    Yoshida T; Ohe C; Tsuzuki T; Sugi M; Kinoshita H; Tsuta K; Matsuda T
    Int J Clin Oncol; 2020 Mar; 25(3):464-471. PubMed ID: 31531786
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.